anemia

In a retrospective study of 75,660 singleton pregnancies, 7,977 women were diagnosed with iron deficiency anemia when they were admitted for delivery.

More than half of the approximate 30 million people in the United States living with chronic kidney disease are iron deficient, and yet, this is the only tablet that has been developed and approved specifically to address iron deficiency anemia in these patients, who are not on dialysis, said Steven Fishbane, M.

Iron deficiency anemia was determined by low serum ferritin levels and low hemoglobin levels that were determined according to age and sex-defined values.

Bhutta cited the Institute for Health Metrics and Evaluation (University of Washington): The Global Burden of Diseases, Injuries and Risk Factors (GBD) 2010 study showed that at a global level and between 1990 and 2010, the burden that the world has with concomitant iron deficiency anemia and related to nutritional factors remains large.

Microcytosis and hypochromia are the common presentations of both the disease processes of iron deficiency anemia (IDA) and beta-thalassemia trait (ssTT).

According to the WHO, almost 20% of [8] all women of the childbearing age in United States were suffering from iron deficiency anemia as compared to 2 % of adult males.

Methods: Eighty-three newly diagnosed iron deficiency anemia patients and 70 healthy controls were included in this study.

Differentiating iron deficiency anemia from thalassemia minor by using an RDW-based index.

Objective: To find out the association between iron deficiency anemia and the frequency of first febrile seizure.

Material and Methods: One hundred and forty two children selected through non probability purposive sampling having iron deficiency anemia were included in the study.

USPRwire, Fri Apr 08 2016] Global Markets Direct's, 'Iron Deficiency Anemia - Pipeline Review, H1 2016', provides an overview of the Iron Deficiency Anemia pipeline landscape.

M2 EQUITYBITES-March 17, 2016-AMAG Pharmaceuticals enrolls first patient under head-to-head, Phase 3 clinical trial to evaluate the safety of Feraheme in adults with iron deficiency anemia

M2 PHARMA-March 17, 2016-AMAG Pharmaceuticals enrolls first patient under head-to-head, Phase 3 clinical trial to evaluate the safety of Feraheme in adults with iron deficiency anemia

Iron deficiency anemia (IDA) is one of the most common diseases.

Preventive Services Task Force announced that it is unsure whether pregnant women who are asymptomatic for iron deficiency anemia should be screened for this condition or take iron supplements.